As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles now introduces — polymeric nanoparticles production services to research communities for R&D and commercialization in a variety of application areas. CD Bioparticles provides such custom services for researchers to design and synthesize polymeric carriers with special required drug loading, together with its analysis and characterization before and after encapsulation.
Polymeric nanoparticles are manipulatable materials and have the potential of reabsorption in the body, which have favorable properties such as good biocompatibility, easy design and preparation, a variety of structures and interesting bio-mimetic characters, and have the ability to deliver therapeutic agents directly into the intended site of action with superior efficacy. In recent decades, polymeric nanoparticles are widely used in the field of drug delivery, and now CD Bioparticles provides custom formulation service to meet global researchers' need to use polymeric nanoparticles as drug carriers.
CD Bioparticles is specialized in the development of drug delivery systems and customizing nanoparticles for drug delivery utilizing its core technologies. In addition to services, CD Bioparticles also offers well-designed drug-loaded polymeric nanoparticle products based on chitosan, PMMA, PHA, PLGA matrix and so on. Researchers may select the material type, particle size, size distribution, and surface functional groups such as carboxyl or amine groups.
"With our high-quality products and services, the efficacy of your drug delivery can be tremendously improved. These new services allow our customers to process their study projects more faster, enabling more rapid results. We're glad to work on this polymeric nanoparticles production service with researchers in related fields and look forward to future joint projects that support the research community's pursuit of success." said Prof. Jeffrey A. Depaul, M.D., the chief scientific officer of R&D department of CD Bioparticles.
"We always strive to provide the highest quality product and relevant supporting services for researchers working on scientific issues. As the need of polymeric nanoparticles production services continues to increase, we decide to offer them such services and hope these changes will advance the research missions of our customers." said Dr. Robin J. Watts, the scientific officer of R&D department of CD Bioparticles. "We are committed to offering such new services and products quickly and widely at CD Bioparticles to support scientists who aim to solve research problems."
For more detailed information on polymeric nanoparticles production services, please contact CD Bioparticles directly at 1-631-619-7922.
About CD Bioparticles
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. It specializes in a range of formulation and drug delivery technologies, from conventional liposomes, PEGylated liposomes for drug delivery to polymer microspheres and nanoparticles for enhanced drug delivery. It provides contract services of drug delivery formulation developments for basic research, formulation feasibility studies, process development and scale-up, formulation characterization, analytical and nonclinical services.
Release ID: 88955638